Next-Generation Sequencing Trends: Kalorama Survey of Laboratories
Next-Generation Sequencing Trends: Kalorama Survey of Laboratories identifies some of the key changes taking place with both next-generation sequencing (NGS) systems in relation to their usage in labs and in relation to the sequencing of clinical samples for diagnostic or clinical research purposes. The report surveys the following aspects of NGS systems: system installations; sequencer applications, clinical applications, and usage trends; preferences and evaluations; and future purchase plans.
This survey – of 78 laboratories, carried out from August to October of 2017 – reached a mix of labs, providing both a range of industry segments as well as groups of labs with both next-generation and capillary systems.
The survey presents results in terms of the types of systems installed by model, by region, by industry, and by lab function.
Responses related to labs’ usage of sequencers in terms of the applications and sample types for which they are run are also provided. Other areas covered include outsourcing and future expectations. The survey also provides segmentation of the applications expected to increase, by brand of next-generation system owned.
The survey gives labs’ feedback with regard to the most important criteria for sequencer purchase, including cost of system, cost per sample or run, raw accuracy, ease of use, and other factors. Further, the survey provides this information with respect to the brand or type of sequencer system owned.
Finally, the survey provides responses related to labs’ plans to for future purchase of sequencers.